- Corporate Officers - K
- Kazam Joshua A
Insider Trading History of Kazam Joshua A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kazam Joshua A since 2008.
This trader's CIK number is 1221355.
At the time of last reporting, Kazam Joshua A was the Officer of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO).
Also see all insider trading activities at Allogene Therapeutics, Inc..
Note that in the past
Kazam Joshua A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allogene Therapeutics, Inc. (ALLO) by Kazam Joshua A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ALLO | 15,000 | $189,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Target Hospitality Corp. (EAGL) by Kazam Joshua A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | EAGL | 10,000 | $101,650 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Latch, Inc. (LTCH) by Kazam Joshua A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | LTCH | 0 | $0 | 0 | $0 | 30,000 | $0 |
Yearly summary of insider trading at Capricor Therapeutics, Inc. (CAPR) by Kazam Joshua A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | CAPR | 7,096 | $24,999 | 0 | $0 | 0 | $0 |
| 2012 | CAPR | 125,000 | $0 | 0 | $0 | 0 | $0 |
| 2010 | CAPR | 50,000 | $0 | 0 | $0 | 0 | $0 |
| 2009 | CAPR | 198,138 | $382 | 0 | $0 | 0 | $0 |
| 2008 | CAPR | 13,800 | $15,467 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tishman Speyer Innovation Corp. Ii (TSIB) by Kazam Joshua A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TSIB | 25,000 | $0 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Kazam Joshua A:
1. Allogene Therapeutics, Inc. (ALLO)
2. Target Hospitality Corp. (EAGL)
3. Latch, Inc. (LTCH)
4. Capricor Therapeutics, Inc. (CAPR)
5. Tishman Speyer Innovation Corp. Ii (TSIB)
Table 1. Insider trading of Allogene Therapeutics, Inc. (ALLO) by Kazam Joshua A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-12 | ALLO | Buy | 15,000 | 12.60 | 189,000 |
Table 2. Insider trading of Target Hospitality Corp. (EAGL) by Kazam Joshua A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-03-05 | EAGL | Buy | 5,000 | 10.20 | 51,000 |
| 2019-03-01 | EAGL | Buy | 5,000 | 10.13 | 50,650 |
Table 3. Insider trading of Latch, Inc. (LTCH) by Kazam Joshua A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-04 | LTCH | Option Ex | 30,000 | .00 | 0 |
Table 4. Insider trading of Capricor Therapeutics, Inc. (CAPR) by Kazam Joshua A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-01-21 | CAPR | Buy | 7,096 | 3.52 | 24,999 |
| 2012-03-30 | NLTX | Buy | 125,000 | .00 | 0 |
| 2010-04-22 | NLTX | Buy | 50,000 | .00 | 0 |
| 2009-07-07 | NLTX | Buy | 197,628 | .00 | 0 |
| 2009-03-12 | NLTX | Buy | 510 | .75 | 382 |
| 2008-12-16 | NLTX | Buy | 3,100 | 1.15 | 3,564 |
| 2008-12-15 | NLTX | Buy | 2,500 | 1.05 | 2,625 |
| 2008-12-11 | NLTX | Buy | 4,100 | .82 | 3,374 |
| 2008-12-12 | NLTX | Buy | 4,100 | 1.44 | 5,904 |
Table 5. Insider trading of Tishman Speyer Innovation Corp. Ii (TSIB) by Kazam Joshua A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-12 | TSIB | Buy | 25,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kazam Joshua A
(Officer of Allogene Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.